EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

From ‘junk’ to medicine: the therapeutic potential of dark transcriptome-derived long noncoding RNA

Omar F Khan

Nucleic Acid Insights · 29.04.2026 · 3 (3) · 167–172

DOI: 10.18609/nuc.2026.022 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acid Insights, online erschienen am 29.04.2026. Verfasst von Omar F Khan. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

“Being creative about what we can deliver with LNPs is critical...” Jokūbas Leikauskas, Editor, Nucleic Acid Insights, speaks with Omar F Khan, Assistant Professor in BME and Immunology, Canada Research Chair in Nucleic Acid Therapeutics, University of Toronto, about the emerging field of dark transcriptome medicines, the therapeutic potential of long noncoding RNA, and the critical role of lipid nanoparticle delivery systems in realizing their clinical promise.

Zitieren

APA

Khan, O. F. (2026). From ‘junk’ to medicine: the therapeutic potential of dark transcriptome-derived long noncoding RNA. Nucleic Acid Insights, 3(3), 167–172. https://doi.org/10.18609/nuc.2026.022

Vancouver

Khan OF. From ‘junk’ to medicine: the therapeutic potential of dark transcriptome-derived long noncoding RNA. Nucleic Acid Insights. 2026;3(3):167–172. doi:10.18609/nuc.2026.022

BibTeX
@article{Khan2026,
  author = {Khan, Omar F},
  title = {From ‘junk’ to medicine: the therapeutic potential of dark transcriptome-derived long noncoding RNA},
  journal = {Nucleic Acid Insights},
  year = {2026},
  volume = {3},
  number = {3},
  pages = {167–172},
  doi = {10.18609/nuc.2026.022}
}
Kostenlos starten →